Posted on | Posted on John Murphy | Leave a Comment on Peripheral Immune-Mediated Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Cross-Sectional Study in a Referral Center

Peripheral Immune-Mediated Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Cross-Sectional Study in a Referral Center

Abstract Background: There are currently seven coronaviruses that can infect humans and the latest addition to these viruses is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Infection by SARS-CoV-2 is…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

Baneet Kaur • Cyril Blavo • Mayur S. Parmar, DOI: 10.7759/cureus.56025  Abstract Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613  Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Inflammatory and Coagulation Marker Changes -Treated COVID-19 Patients

Inflammatory and Coagulation Marker Changes -Treated COVID-19 Patients

Akinari Tsukada • Daisuke Katagiri • Shinyu Izumi et. al., DOI: 10.7759/cureus.78836  Abstract Introduction Direct hemoperfusion using polymyxin B-immobilized polystyrene fiber column (PMX-DHP) removes endotoxin and inflammatory mediators from the blood. This study aimed to evaluate…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Post-COVID-19 Inflammatory Arthritis Treated With Upadacitinib: A Case Report

Post-COVID-19 Inflammatory Arthritis Treated With Upadacitinib: A Case Report

Cherie S. Zhi • Ami Ben-Artzi, DOI: 10.7759/cureus.78799  Abstract Two patients who developed inflammatory arthritis following COVID-19 infection are presented, characterized by arthralgias, arthritis, and elevated markers of inflammation (C-reactive protein). Both patients…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Biden officials knew about potential COVID-19 vaccine risks — and took steps to downplay them, scathing Senate report

Biden officials knew about potential COVID-19 vaccine risks — and took steps to downplay them, scathing Senate report

By Ryan King, New York Post Top federal health officials actively took steps to “delay warning the public” for months in 2021 about the potential risks of heart-related complications from receiving…[...]

Read More